CEO & President of Vertex Pharmaceuticals Inc (VRTX, Financial) Jeffrey M Leiden sold 56,030 shares of VRTX on 06/18/2019 at an average price of $175.39 a share. The total sale was $9.8 million.
Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets. Its products include SYMDEKO, ORKAMBI, and KALYDECO. Vertex Pharmaceuticals Inc has a market cap of $46.66 billion; its shares were traded at around $182.17 with a P/E ratio of 21.94 and P/S ratio of 14.50.
CEO Recent Trades:
- CEO & President Jeffrey M Leiden sold 56,030 shares of VRTX stock on 06/18/2019 at the average price of $175.39. The price of the stock has increased by 3.87% since.
- CEO & President Jeffrey M Leiden sold 113,432 shares of VRTX stock on 05/24/2019 at the average price of $175.1. The price of the stock has increased by 4.04% since.
Directors and Officers Recent Trades:
- EVP\Chief Commercial Officer Stuart A Arbuckle sold 2,125 shares of VRTX stock on 06/19/2019 at the average price of $181.89. The price of the stock has increased by 0.15% since.
- Director Sangeeta N. Bhatia sold 720 shares of VRTX stock on 06/03/2019 at the average price of $167.08. The price of the stock has increased by 9.03% since.
For the complete insider trading history of VRTX, click here
.
